Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cardinal Health ( (CAH) ) has provided an announcement.
On February 5, 2026, Cardinal Health reported strong second-quarter fiscal 2026 results, with revenue rising 19% year over year to $65.6 billion, GAAP operating earnings up 29% to $707 million and non-GAAP operating earnings up 38% to $877 million, driving a 36% increase in non-GAAP diluted EPS to $2.63. The Pharmaceutical and Specialty Solutions segment remained the main growth engine, with revenue up 19% to $60.7 billion and segment profit up 29% to $687 million, supported by brand and specialty drug sales, acquisitions of MSO platforms and positive generics performance, while the Global Medical Products and Distribution segment delivered 3% revenue growth to $3.3 billion and a 106% jump in profit to $37 million on customer volume growth and cost optimization efforts. Reflecting this broad-based profit expansion and a lower share count, the company raised its fiscal 2026 non-GAAP EPS guidance to $10.15–$10.35, completed a $750 million baseline share repurchase and reached its targeted leverage range, signaling increased financial flexibility and confidence in ongoing operational momentum.
The most recent analyst rating on (CAH) stock is a Buy with a $245.00 price target. To see the full list of analyst forecasts on Cardinal Health stock, see the CAH Stock Forecast page.
Spark’s Take on CAH Stock
According to Spark, TipRanks’ AI Analyst, CAH is a Neutral.
The score is driven by strong operating momentum and raised guidance from the latest earnings call, supported by robust cash flow. This is tempered by balance-sheet weakness (negative equity/leverage) and a relatively expensive valuation, while technical signals are neutral-to-mixed.
To see Spark’s full report on CAH stock, click here.
More about Cardinal Health
Cardinal Health is a global healthcare services and products company that operates primarily in pharmaceutical distribution and medical products and distribution. Through its Pharmaceutical and Specialty Solutions segment, the company distributes brand, generic and specialty pharmaceuticals to a range of healthcare providers, while its Global Medical Products and Distribution segment supplies medical products and logistics services to hospitals and other care settings, with a focus on scale, efficiency and cost optimization in the healthcare supply chain.
Average Trading Volume: 2,073,520
Technical Sentiment Signal: Buy
Current Market Cap: $49.15B
Learn more about CAH stock on TipRanks’ Stock Analysis page.